Walgreens tackles declining profits, store closures, and rising costs. Learn about Sycamore Partners' acquisition offer of ...

According to TipRanks.com, Lutz is a 5-star analyst with an average return of 9.7% and a 60.8% success rate. Lutz covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, ...

The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth quarter of this year.

During the quarter, Walgreens recorded a $1 billion gain from the sale of a portion of its stake in Cencora and from returns on its investment in BrightSpring, both part of its healthcare portfolio.

But Walgreens made $1 billion in profit by cashing out early on some of its shares of Cencora, a pharmaceutical solutions organization, and benefiting from gains from its investment in ...

Lutz covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Hims & Hers Health, and Envista Holdings. Cencora has an analyst consensus of Moderate Buy, with a price ...

Walgreens Boots Alliance is one of the largest ... think the firm will need to either raise additional debt or sell more Cencora shares that it owns to meet its liabilities. However, over the ...

April 08, 2025--(BUSINESS WIRE)--Walgreens Boots Alliance ... prepaid forward derivatives related to the monetization of Cencora shares and gains on investments in BrightSpring.

Renewed collaborations with Express Scripts and Walgreens strengthen core distribution capabilities and align resources to meet customer needs effectively. Cencora operates in a highly competitive ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.